🇺🇸 FDA
Pipeline program

LUM001

LUM001-201

Phase 2 small_molecule completed

Quick answer

LUM001 for PBC is a Phase 2 program (small_molecule) at Mirum Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Mirum Pharmaceuticals
Indication
PBC
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials